AMLX Amylyx Pharmaceuticals, Inc. | US03237H1014
| Metric | Current | 31.03.2026 | 31.12.2025 | 30.09.2025 |
|---|---|---|---|---|
| Market Cap | 2.046.940.160 | 1.543.267.987,95 | 1.327.404.775,78 | 1.491.725.148,13 |
| Enterprise Value | 1.772.803.072 | 1.319.762.987,95 | 1.106.710.775,78 | 1.272.482.148,13 |
| Trailing P/E | - | - | - | - |
| Forward P/E | -13,51 | - | - | - |
| Price to Sales | - | - | - | - |
| Price to Book | 7,48 | 5,65 | 4,35 | 4,49 |
| EV/Revenue | - | - | - | - |
| EV/EBITDA | -11,16 | - | - | - |